Effect of a Semi-Presence Yoga Program on Primary Dysmenorrhea
Launched by UNIVERSITY OF HUELVA · Mar 2, 2020
Trial Information
Current as of July 09, 2025
Unknown status
Keywords
ClinConnect Summary
Dysmenorrhea affects between 50% and 90% of women of childbearing age worldwide, the figure is estimated to be 74.8% in Spain. In addition to pain, other menstrual symptoms affect the normality of those with it, and it is found to cause absenteeism at work and school and influence academic performance. Self-medication with painkillers is one of the most used self-care measures by women with dysmenorrhea despite not being the most appropriate. So, in recent decades new lines are being investigated that can help reduce the impact of the problem on women with dysmenorrhea.
According to severa...
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • • Nulliparous women who exhibit moderate-severe pain, 4-10 according to VAS, associated with menstruation in their last cycle, have no history of diagnosed gynecological pathology, and have an internet access device (mobile, computer or table).
- Exclusion Criteria:
- • • Those who do not meet the criteria for inclusion or do not wish to participated voluntarily, suffer from any other illnesses associated with pain or limiting physical exercise, as well as exclude women who already perform yoga.
About University Of Huelva
The University of Huelva is a renowned academic institution dedicated to advancing research and innovation in the field of health sciences. With a strong emphasis on interdisciplinary collaboration, the university actively sponsors clinical trials aimed at improving patient outcomes and enhancing therapeutic strategies. Leveraging its extensive network of experts and state-of-the-art facilities, the University of Huelva fosters a rigorous research environment that prioritizes ethical standards and scientific integrity, ultimately contributing to the advancement of medical knowledge and public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Huelva, Andalucía, Spain
Huelva, , Spain
Patients applied
Trial Officials
Ana Abreu Sánchez, PhD
Study Director
Universidad de Huelva, Facultad de Enfermería
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials